JBMR Plus

Higher vitamin K status not linked to less bone loss

An observational analysis of 771 US adults over two years also found no link between initial vitamin K status and bone-density responses to vitamin D.

Studied:
Cohort study of 687 generally healthy adults, 2-yr, against participants with lower vitamin K status (Double-blind, placebo-controlled, registered NCT04573946)
What changed:
Bone loss did not differ overall between participants with higher and lower vitamin K status over 2-yr follow-up
The catch:
Smoking and alcohol use differed by vitamin K status but were not adjustment factors
In the record:
The 328th paper on cholecalciferol with results in people; 481 on record in all.

Editor of record: Boris Djordjevic · AgingResearch.News

Follow @agingbrief

In 771 US men and women averaging 63.8 years old, researchers examined whether initial vitamin K status was linked to bone-density changes over two years. Women made up 46.7% of participants. This observational analysis used data from a randomized trial comparing 2,000 international units of vitamin D₃ daily with placebo.

Researchers assessed vitamin K status using three blood measures. Of the original participants, 687 completed follow-up bone-density scans. Higher initial vitamin K status was not linked to more favorable changes in bone density at the spine, hip or whole body, or in bone structure at the forearm and shin. Initial vitamin K status also did not modify vitamin D’s effects on bone density. Vitamin D itself produced no difference in bone-density changes compared with placebo.

Why it matters

Vitamin D stimulates production of a bone protein that vitamin K activates. This relationship raises the question of whether vitamin K status matters for efforts to preserve bone health in older adults.

Caveats

Vitamin K status was observed rather than randomized, so this was not a test of vitamin K supplements. Participants came from the Boston area; the trial excluded people with prior cardiovascular disease, most cancers and several serious illnesses.

From the paper

Participants

About 388 participants were randomized to active vitamin D₃ intervention, and 383 were randomized to vitamin D placebo.

Results, Baseline characteristics of the bone health sub-cohort

Quoted word for word from the full text on PubMed Central.

Comments

Be the first to comment.